Mar 14 |
Sol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
|
Mar 14 |
Sol-Gel Technologies GAAP EPS of -$1.01 misses by $0.31, revenue of $1.55M misses by $0.85M
|
Mar 13 |
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
|
Nov 30 |
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study
|
Nov 20 |
Is Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 24% Discount?
|
Nov 9 |
Sol-Gel Technologies GAAP EPS of -$0.21 beats by $0.02, revenue of $0.21M misses by $0.48M
|
Nov 9 |
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
Oct 31 |
Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies
|
Oct 30 |
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
|